| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.08 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.09 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.09 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |